Allen Nissenson
CIK 1441889 · Chief Medical Officer · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.32M
Companies
4
Total Filings
32
Lifetime Open-Market Net
-$2.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RMTI | Director | 23,892 | $6.99 | $167.0K | $0 | 8 | 2026-07-06 |
| ELTX | Director | — | $2.95 | — | $0 | 3 | 2025-05-20 |
| Elicio Therapeutics, Inc. (ANGN) Delisted | Director | 938 | $10.00 | $9.4K | $10.9K | 3 | 2022-06-13 |
| DVA | Chief Medical Officer | 8,990 | $239.46 | $2.15M | -$2.79M | 18 | 2014-02-18 |
Recent Filings · Page 2 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-22 | RMTI | Grant (A) | +50,000 | $0 | EDGAR |
| 2021-03-10 | Elicio Therapeutics, Inc. (ANGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-15 | RMTI | Grant (A) | +1,488 | $0 | EDGAR |
| 2020-06-12 | RMTI | Grant (A) | +23,000 | $0 | EDGAR |
| 2014-02-18 | DVA | Mixed | +6,030 | -$168.5K | EDGAR |
| 2013-12-18 | DVA | Mixed | — | -$175.3K | EDGAR |
| 2013-05-15 | DVA | Mixed | — | -$101.3K | EDGAR |
| 2013-03-22 | DVA | Grant (A) | — | $0 | EDGAR |
| 2013-03-21 | DVA | Exer (M) | — | $0 | EDGAR |
| 2013-03-08 | DVA | Mixed | — | -$299.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.